Switzerland: Biotechnology New Concept in Biological Manufacturing and Development

Lonza announced the launch of a new biological development and manufacturing concept, coupling flexibility in facility-build-out with tailored business models.

Visp/Switzerland — According to the company, the concept called Ibex Solutions is leveraging their expertise and service network in Visp (CH). Construction began in June with a formal groundbreaking ceremony expected in the second half of 2017. Several hundred new positions are expected to be created.

Ibex biomanufacturing comprises a modular, technology-independent development and manufacturing complex capable of supporting activities across multiple technologies — mammalian, microbial, cellular or bio-conjugate, the company claims. This flexibility would give customers freedom in facility design and implementation, and the ability to respond rapidly as their needs evolve.

Switzerland: Biopharmaceutical Industry

Lonza Acquires Hanse Biomed Life Sciences and Invests in Exosomics

The concept includes flexible models to match and adapt to individual customer’s expectations and forecasts. The company states that the availability of a modular complex would mean time-to-market could be reduced by 12 months or more.

(ID:44806194)